Steven F. Ziegler

Steven F. Ziegler

Auto-generated profile, based on publicly available information

Steven F. Ziegler

Benaroya Research Institute

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2003 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MRMindi R.Walker
Mindi R.Walker
DKDeborah J. Kasprowicz
Deborah J. Kasprowicz
VGVivian H. Gersuk
Vivian H. Gersuk
ABAngéle Bènard
Angéle Bènard
MLMegan Van Landeghen
Megan Van Landeghen
SZSteven F. Ziegler
Steven F. Ziegler
CD4+CD25+ regulatory T (TR) cells have been described in both humans and mice. In mice, TR are thymically derived, and lack of TR leads to organ-specific autoimmunity. Recently, the forkhead/winged helix transcription factor, FoxP3, has been shown to be important for the function of TR cells in mice. In this study, human TR cells were examined and, in results similar to those of studies done in mice, expression of FoxP3 was found exclusively in CD4+CD25+ T cells and correlated with the suppressive activity of these cells. In contrast to the mouse studies, activation of human CD4+CD25– T cells led to expression of FoxP3. Expression of FoxP3 in activated human CD4+CD25+ cells also correlated with suppression of proliferation by these cells in freshly isolated CD4+CD25– T cells from the same donor. This suppression was cell-contact dependent and cytokine independent. Thus, in humans, during activation of CD4+CD25– T cells in an immune response, two populations of cells may arise, effector CD4+CD25+ and regulatory CD4+CD25+ T cells, with expression of FoxP3 correlated with regulatory activity. These data also raise the possibility that a failure to generate peripheral TR cells properly may contribute to autoimmune disease and suggest a possible therapeutic role for FoxP3 in the treatment of such diseases.

15 August 2005 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JYJane Yoo
Jane Yoo
MOMiyuki Omori
Miyuki Omori
DGDora Gyarmati
Dora Gyarmati
BZBaohua Zhou
Baohua Zhou
TATheingi Aye
Theingi Aye
SZSteven F. Ziegler
Steven F. Ziegler
The cytokine thymic stromal lymphopoietin (TSLP) has recently been implicated in the pathogenesis of atopic dermatitis (AD) and other allergic diseases in humans. To further characterize its role in this disease process, transgenic mice were generated that express a keratinocyte-specific, tetracycline-inducible TSLP transgene. Skin-specific overexpression of TSLP resulted in an AD-like phenotype, with the development of eczematous lesions containing inflammatory dermal cellular infiltrates, a dramatic increase in Th2 CD4+ T cells expressing cutaneous homing receptors, and elevated serum levels of IgE. These transgenic mice demonstrate that TSLP can initiate a cascade of allergic inflammation in the skin and provide a valuable animal model for future study of this common disease.

19 March 2010 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
SZSteven F Ziegler
Steven F Ziegler
DADavid Artis
David Artis

1 April 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
FRFlorence Roan
Florence Roan
KOKazushige Obata-Ninomiya
Kazushige Obata-Ninomiya
SZSteven F. Ziegler
Steven F. Ziegler
The epithelial cell–derived cytokines thymic stromal lymphopoietin (TSLP), IL-33, and IL-25 are central regulators of type 2 immunity, which drives a broad array of allergic responses. Often characterized as “alarmins” that are released by the barrier epithelium in response to external insults, these epithelial cell–derived cytokines were initially thought to act only early in allergic inflammation. Indeed, TSLP can condition dendritic cells to initiate type 2 responses, and IL-33 may influence susceptibility to asthma through its role in establishing the immune environment in the perinatal lungs. However, TSLP, IL-33, and IL-25 all regulate a broad spectrum of innate immune cell populations and are particularly potent in eliciting and activating type 2 innate lymphoid cells (ILC2s) that may act throughout allergic inflammation. Recent data suggest that a TSLP/ILC axis may mediate steroid resistance in asthma. Recent identification of memory Th2 cell subsets that are characterized by high receptor expression for TSLP, IL-33, and IL-25 further supports a role for these cytokines in allergic exacerbations. There is therefore growing interest in developing biologics that target TSLP, IL-33, and IL-25. This Review provides an overview of TSLP, IL-33, and IL-25 and the development of blocking antibodies that target these epithelial cell–derived cytokines.

16 January 2007 in Proceedings of the National Academy of Sciences of the United States of America
Verified
Journal Article
Closed access
HLHai-Chon Lee
Hai-Chon Lee
SZSteven F. Ziegler
Steven F. Ziegler
The epithelial-derived cytokine thymic stromal lymphopoietin (TSLP) is important for the initiation of allergic airway inflammation through a dendritic cell-mediated T helper 2 response. To identify the factors that control TSLP expression, we examined the ability of inflammatory mediators to regulate TSLP production in human airway epithelial cells. We found that both IL-1β and TNF-α were capable of inducing rapid TSLP production in primary human bronchial airway epithelial cells. We further characterized the human TSLP gene promoter, using two human epithelial cell lines, 16HBEo−and A549, and showed that IL-1β- and TNF-α-mediated human TSLP promoter activation in these cells was mediated by an upstream NFκB site. Mutation of this NFκB site abolished activation, as did overexpression of a dominant-negative version of IκB kinase (IKK)β (a kinase acting on IκB, the inhibitor of NFκB). Interestingly, human TSLP mRNA levels were also increased after exposure to Toll-like receptor (TLR) 2, TLR8, and TLR9 ligands, further supporting an important role for NFκB in TSLP gene regulation. Similarly, analysis of the mouse TSLP gene promoter revealed the presence of a similarly situated NFκB site that was also critical for IL-1β-inducible expression of mouse TSLP. Taken together, these results demonstrate that the inflammatory mediators IL-1β and TNF-α regulate human TSLP gene expression in an NFκB-dependent manner.

1 January 2013
Verified
Book Chapter
Closed access
SZSteven F. Ziegler
Steven F. Ziegler
FRFlorence Roan
Florence Roan
BBBryan D. Bell
Bryan D. Bell
TSThomas A. Stoklasek
Thomas A. Stoklasek
MKMasayuki Kitajima
Masayuki Kitajima
HHHongwei Han
Hongwei Han